Exhibition
Sept. 4 - 7, 2025 | Orlando, Florida
ASNC2025 Exhibition and Sponsored Events
ASNC2025 offers valuable opportunities to engage with ASNC’s esteemed industry partners. Through expert insights and hands-on guidance, they will help you and your team harness the latest tools and technologies, keeping your lab at the forefront of clinical excellence.
Friday, Sept. 5
7:00 AM – 8:15 AM
Breakfast Symposium Sponsored by AstraZeneca Ionis
Title: Health Disparities in hATTR
This session explores the health disparities associated with hereditary transthyretin amyloidosis (hATTR), a rare genetic condition characterized by the abnormal deposition of amyloid protein in various organs and tissues. We will delve into the epidemiology of hATTR, highlighting how genetic predispositions, geographic distribution, and socioeconomic factors contribute to disparities in diagnosis and treatment access.
Speaker: Saurabh Malhotra, MD, MPH, FASNC
12:15 PM – 1:15 PM
Lunch and Learn Sponsored by Bracco Diagnostics
Title: From Discordance to Diagnostic Cohesion: Demystifying CAD with Coronary Flow Capacity
Description: In this talk we will review the challenges of accurately assessing obstructive coronary artery disease and appropriate risk determination by reviewing the principles behind coronary perfusion as it applies to microvascular and epicardial coronary disease and how this is assessed using current assessment modalities; functional testing, perfusion testing, angiography, invasive hemodynamic assessments, and myocardial blood flow assessment, with a special focus on coronary flow capacity and recent innovations in evaluating subendocardial ischemia.
Speaker: Sergey Kachur, MD, FACC
3:45 PM – 4:45 PM
Cases Over Cocktails and Cookies
Join Bracco Diagnostics, GE HealthCare, and Jubilant Radiopharma during the Friday afternoon break for a series of engaging case presentations, all while savoring signature cocktails and cookies. Relax, learn, and connect in this informative break session.
-
Bracco Diagnostics
Surgery Averted: The Case of the False Positive AngiogramExplore a compelling case of significant visual disease and how cardiac PET and coronary flow capacity helped avoid inappropriate surgical intervention.
Speaker: Dr. Robert Bober, Nuclear Cardiologist at Sutter East Bay Medical Group, Oakland, CA
Signature cocktail: “The Gould Standard” – Gin Mango Refresher (mocktail version available)
-
GE HealthCare
Seeing More, Reaching Further: The Future of Cardiac PET
Join Dr. Mouaz Al-Mallah as he shares clinical cases that demonstrate how cardiac PET imaging with an F-18 radiotracer supports accurate diagnosis and risk assessment. He will also discuss how the practical advantages of F-18 are helping make advanced cardiac imaging accessible to a broader range of patients.
Speaker: Mouaz H. Al-Mallah, MD, MSc, MASNC
Signature cookie: Sugar Cookie
-
Jubilant Radiopharma
Understanding the Role of Cardiac PET: Case Presentations
Explore the role of cardiac PET in the evaluation of myocardial disease, appreciate the differences and benefits of cardiac PET versus cardiac SPECT imaging, and understand the use of PET with Rb-82 through various patient case studies.
Speaker: Dr. Gary Small, University of Ottawa Heart Institute
Signature cocktail: “RUBY Royale” – Champagne and Crème de Cassis
Saturday, Sept. 6
7:00 AM – 8:15 AM
Breakfast Symposium Sponsored by Alnylam Pharmaceuticals
Join Alnylam Pharmaceuticals and their distinguished faculty as they review the clinical profile of AMVUTTRA for the treatment of cardiomyopathy of transthyretin-medicated amyloidosis (ATTR-CM) in adults.
Speaker: Dia Smiley, DO
12:15 PM – 1:15 PM
Lunch and Learn Sponsored by Pfizer
Cardiac Amyloidosis in Focus: Nuclear Imaging Insights and Treatment Strategies
Transthyretin Cardiac Amyloidosis (or ATTR-CM) is a serious, underrecognized and underdiagnosed cause of heart failure. Join us to help raise awareness of the signs and symptoms of ATTR-CM and the role of Nuclear Imaging in confirming ATTR-CM. Through patient case study and expert perspectives, this program will explore the patient journey for ATTR-CM, including sharing long-term extension data and published findings from a real-world study for treatment options.
Speaker: Vasvi Singh, MD, FASNC, FSCCT, FACC
Sunday, Sept. 7
6:45 AM - 8:15 AM
CME Breakfast Symposium: The Evolving Landscape of ATTR Cardiomyopathy
Led by Program Chair Prem Soman, MD, PhD, MASNC, this session will show you how to enhance early disease detection; highlight advances in noninvasive imaging that minimize missed, inaccurate, and delayed diagnoses; examine how new and emerging therapies impact therapeutic decision-making and understand knowledge gaps in TTR amyloidosis.
This session is supported by an unrestricted educational grant from BridgeBio.
These sessions are not part of the official ASNC2025 Annual Scientific Session as planned by the Program Committee.
Thank You to Our ASNC2025 Sponsors
PLATINUM
GOLD
SILVER
BRONZE
Thank You to Our ASNC2025 Exhibitors
Alnylam Pharmaceuticals
AstraZeneca Ionis
Best Medical International
Bracco Diagnostics
BridgeBio
Cardiac Imaging
Cardinal Health
Cardiovascular Imaging Technologies (CVIT)
Catalyst MedTech
CDL Nuclear
Cedars-Sinai Medical Center
Comecer
GE HealthCare
Image One Medical Group
Inter Medical Medizintechnik GmbH
Intersocietal Accreditation Commission (IAC)
INVIA
Jubilant Radiopharma
MedTrace Pharma
MIE America
Modern Nuclear
Molecular Imaging Services (MIS)
Pfizer
Positron Corporation
Shared Medical Services
SIEMENS
Spectrum Dynamics
Studycast by Core Sound Imaging
SynterMed
United Imaging
Upbeat Cardiology
Vascular Imaging Professionals
Interested in Sponsorship Opportunities at ASNC2025?
Please view the ASNC2025 Sponsorship Prospectus and contact Megan LaVine, Director of Industry and Development at mlavine@asnc.org to secure your sponsorship.
Our Expo Hall is now sold out.
